Questcor Pharmaceutical News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.04.17	Matson Announces Quarterly Dividend Of $0.19 Per Share (PR Newswire)
23.01.17	Viavi Introduces CERTiFi Cloud-Based Workflow Tailored for Enterprise Test and Certification (PR Newswire)
12.05.14	Mallinckrodt-Questcor Deal Receives U.S. Antitrust Approval - Quick Facts (RTTNews)
29.04.14	Questcor Pharma First Quarter Results Miss Estimates (RTTNews)
29.04.14	Questcor Profit Rises, Yet Misses Estimate (RTTNews)
08.04.14	IMMU Chugs Along, MNKD Decision Delayed, QCOR Bought Out, Another First For ISR (RTTNews)
07.04.14	Mallinckrodt To Buy Questcor For $5.6 Bln In Cash And Stock (RTTNews)
07.04.14	Mallinckrodt And Questcor Pharma To Merge In $5.6 Bln Deal - Quick Facts (RTTNews)
26.02.14	Questcor Pharma Q4 Adj Profit Tops View, But Sales Miss (RTTNews)
26.02.14	Questcor Pharmaceuticals Q4 Profit Rises (RTTNews)
05.02.14	Questcor Pharma Appoints Rajesh Asarpota As CFO - Quick Facts (RTTNews)
30.10.13	Questcor Pharma Third Quarter Results Top Estimates; Stock Down 10% On Probe (RTTNews)
29.10.13	After-market Movers For Oct 29 (LNKD, TTWO, DWA, EA, BIDU, BWLD, YELP, RBCN) (RTTNews)
29.10.13	Questcor Pharma Q3 Profit Rises - Quick Facts (RTTNews)
22.10.13	Questcor To Commence Acthar Phase 2 Study - Quick Facts (RTTNews)
22.10.13	Questcor To Commence Phase 2 Study of Acthar for Acute Respiratory Distress Syndrome (PR Newswire)
17.10.13	Technical Study: Amgen Inc., Questcor Pharmaceuticals Inc., PDL BioPharma Inc., and BioCryst Pharma Inc. (PR Newswire)
16.10.13	Dividend Announcements, Earnings Release Scheduled, and Data Presentations from Clinical Studies - Research Report on Questcor, Regeneron, NPS, Incyte, and Nektar (PR Newswire)
11.10.13	Scheduled Earnings Releases, Survey and Study Results, and Enrollment into Clinical Trial - Research Report on Biogen Idec, Questcor, Medivation, Agenus, and Arrowhead Research (PR Newswire)
10.10.13	Questcor Increases Quarterly Cash Dividend 20 Percent (PR Newswire)
20.09.13	Today's Research: Amgen Inc., BioCryst Pharmaceuticals Inc., PDL BioPharma Inc., and Questcor Pharmaceuticals Inc. (PR Newswire)
03.09.13	Pharmaceuticals Report Revolutionary Findings, Approved Treatments, Investor Conferences - Research Report on Celgene, Amgen, Biogen Idec, Regeneron, and Questcor (PR Newswire)
27.08.13	Questcor Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference (PR Newswire)
21.08.13	Pre-market Movers For Aug 21 (LOW, TGT, SPLS, AEO, INCY, QCOR, DMND) (RTTNews)
14.08.13	Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc. (PR Newswire)
06.08.13	Solid Margins, Financial Strategies, and Earnings Reports Support Long-Term Growth in Biotech - Research Report on Gilead Sciences, Celgene, Onyx Pharmaceuticals, Questcor, and Amgen (PR Newswire)
02.08.13	Expanding R&D Programs, Clinical Trials, Drug Applications and Acquisitions, Advancing to Help Patients with Unmet Medical Needs - Research Report on Questcor, BioMarin, Vanda, Illumina and Theravance (PR Newswire)
31.07.13	Pre-market Movers For July 31 (MA, CMCSA, SODA, APD, SO, IBM, SI, QCOR, RVBD) (RTTNews)
31.07.13	The Fall And Rise Of Questcor (RTTNews)
31.07.13	AEGR Nearing $100, ALXA Grows Richer, CBST's Deal Day, BEAT Hits Right Notes (RTTNews)
31.07.13	Questcor Pharma Shares Jump As Q2 Results Beat View (RTTNews)
31.07.13	After-market Movers For July 30 (SYMC, AMGN, TTWO, CBST, QCOR, RVBD, JIVE, BGFV) (RTTNews)
30.07.13	Questcor Pharma Profit Surges; Stock Up 9% - Quick Facts (RTTNews)
30.07.13	Questcor Reports Second Quarter Financial Results (PR Newswire)
25.07.13	Results Schedules, Management Changes, and Pending NDA Approvals - Research Report on Questcor, VIVUS, Exelixis, Incyte, and Chelsea Therapeutics (PR Newswire)
24.07.13	Questcor to Commence Phase 2 Study of Acthar for ALS (PR Newswire)
11.07.13	Questcor Pharma To Initiate Pilot Commercialization Effort For H.P. Acthar Gel (RTTNews)
30.04.08	Questcor Reports Strong First Quarter 2008 Results (Businesswire)
22.04.08	Questcor to Provide Q1 Results (Businesswire)
25.02.08	Questcor to Host 2007 Fourth Quarter and Full Year Results Conference Call (Businesswire)
15.11.07	Questcor Appoints Stephen Farrell to Board of Directors (Businesswire)
02.11.06	Questcor Announces Financial Results for 2006 Third Quarter (Businesswire)
18.10.06	Questcor Announces Appointment of New Executive Officers (Businesswire)
27.09.06	Questcor Elects David Young, Pharm.D., Ph.D. to Board of Directors (Businesswire)
23.08.06	Questcor beantragt sNDA für Acthar(R) Gel zur Behandlung von West-Syndrom (Infantile Spasms); FDA will Antrag prüfen (Businesswire)
08.08.06	Questcor Announces Financial Results for 2006 Second Quarter; Sales of Acthar Gel Exceed $3 Million; 60% Increase Over First Quarter 2006 (Businesswire)
09.05.06	Questcor Announces Financial Results for the First Quarter of 2006; Net Sales of Acthar Gel Increase 39% Over Fourth Quarter of 2005 (Businesswire)
05.05.06	Questcor Announces the Acquisition of Doral(R) (quazepam); Provides Second Product for National Neurology Sales Force (Businesswire)
02.05.05	Questcor Announces the Addition of Craig Chambliss as Vice President o (Businesswire)
15.03.05	Questcor Announces the Addition of Steve Cartt as Executive Vice Presi (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu Questcor Pharmaceutical Inc.

Aktien Top/Flop

Meistgelesene Nachrichten